Compass Therapeutics (CMPX) Proxy filing summary

Voting matters and shareholder proposals

• Election of two class III directors to serve until the 2029 annual meeting, with nominees Thomas J. Schuetz, M.D., Ph.D., and Richard S. Lindahl, M.B.A.

• Ratification of CohnReznick LLP as independent registered public accounting firm for the fiscal year ending December 31, 2026.

• Advisory vote to approve the compensation of named executive officers.

• Advisory vote on the frequency of future advisory votes regarding executive compensation, with a recommendation for annual votes.

• Proxies are authorized to vote on other business that may arise at the meeting or any adjournment.

Board of directors and corporate governance

• Board recommends voting in favor of all proposals, including director elections and auditor ratification.

• Directors up for election will serve until 2029 or until a successor is duly elected and qualified.

Executive compensation and say-on-pay

• Advisory vote solicited on the compensation of named executive officers.

• Advisory vote solicited on the frequency of future say-on-pay votes, with a recommendation for annual votes.